科学研究
学术论文
当前位置: 首页>>科学研究>>学术论文>>正文

    任雪玲等Photoactivatable RNAi for cancer gene therapy triggered by near-infrared-irradiated single-walled carbon nanotubes

    2017-12-06   点击:[]


    Photoactivatable RNAi for cancer gene therapy triggered by near-infrared-irradiated single-walled carbon nanotubes

    【作者】 Ren X; Lin J; Wang X; Liu X; Meng E; Zhang R; Sang Y; Zhang Z.

    【期刊名】 Int J Nanomedicine

    【影响因子】 2017: 4.3

    【作者单位】 Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases,  School of Pharmaceutical Sciences,  Zhengzhou University, Zhengzhou, People’s Republic of China

    【年,卷():页码】2017, 12: 7885-7896

    【关键词】Hsp70B′ promoter; RNAi; SWNT; near-infrared light response

    【摘要】The efficacy of RNA interference (RNAi)-based cancer gene therapy is limited by its unexpected side effects, thus necessitating a strategy to precisely trigger conditional gene knockdown. In this study, we engineered a novel photoactivatable RNAi system, named as polyetherimide-modified single-wall carbon nanotube (PEI-SWNT)/pHSP-shT, that enables optogenetic control of targeted gene suppression in tumor cells. PEI-SWNT/pHSP-shT comprises a stimulus-responsive nanocarrier (PEI-SWNT), and an Hsp70B'-promoter-driven RNAi vector (pHSP-shT). In response to near-infrared (NIR) light irradiation, heating of PEI-SWNT in breast MCF-7 cells triggered gene knockdown targeting human telomerase reverse transcriptase through RNAi, with the gene-knockdown activity capable of being switched off by extinguishing the NIR. Furthermore, we demonstrated that the photoactivatable RNAi system exhibited higher antitumor activity by combining gene therapy and photothermal therapy, both in vitro and in vivo. Optogenetic control of RNAi based on an NIR-activated nanocarrier will potentially facilitate improved understanding of molecular-targeted gene therapy in human malignant tumors.

    【全文链接】https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666115/


    上一条:​王兵华等Simultaneously overcome tumor vascular endothelium and extracellular matrix barriers via a non-destructive size-controlled nanomedicine
    下一条:侯琳等Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform

    关闭

版权所有:河南省靶向诊疗纳米药物重点实验室

地址:郑州市科学大道100号    邮编:450001